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Gregg M Yamada MD* 
Cholera is the most fatal of the infectious diarrheas but only 
rarely encountered in Hawaii. Two cases previously have been 
documented in the Islands. We describe an elderly patient, without 
obvious risk factors, who contracted cholera. Early consideration 
of cholera as a diagnostic possibility is recommended in patients 
with unexplained, profuse diarrhea. The unique features of this 
case are discussed in this report. 
Case Report 
A 77-year-old Japanese man was admitted to a community 
hospital for weakness and diarrhea. Four days prior to admission 
he had a sudden onset ofloose, watery stools, but denied any other 
symptoms. Over the next 2 days, the severity of the diarrhea 
increased progressively and the patient sought medical attention. 
He was prescribed an antidiarrheal agent with minimal relief. The 
morning of admission, the volume and frequency of diarrhea had 
increased dramatically to 15 episodes per hour; this was associated 
with dizziness, abdominal cramping, and tenesmus. 
There had been no recent ingestion of raw seafood or dairy 
products, and no recent travel or use of an antibiotic. No other 
family member or personal contact had been ill. The patient, a 
retired farmer, lived with his wife and family. 
The patient's past medical history was remarkable for a 
partial gastrectomy curative for peptic ulcer disease, and he also 
had intolerance to lactose. No previous episodes of significant 
diarrhea were reported. 
Physical examination was notable for orthostatic hypotension, 
poor skin turgor, hypophonia and a dry oral mucosa. Abdominal 
and rectal examinations were unremarkable. The stool was green, 
watery and guaiac negative. 
Laboratory examination revealed significant metabolic aci-
dosis, hemoconcentration with elevated hematocrit and serum 
proteins and elevated blood urea nitrogen and serum creatinine. 
Stool Wright stain was negative. Stool culture performed on 
MacConkey' s medium revealed non-lactose-fermenting colonies 
identified as Vibrio cholera through biochemical analysis. 
Serogroup confirmation was performed by the State Department 
of Health. 
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The patient's hospital course was notable for massive diar-
rhea production, often exceeding 1 liter per hour, marked 
hypovolemia, acidosis and acute renal insufficiency. Rehydration, 
electrolyte and bicarbonate repletion was accomplished intrave-
nously in the intensive care unit and Doxycycline was adminis-
tered. The patient was subsequently discharged in stable condition 
on the 6th hospital day. 
Discussion 
Although, in retrospect, our patient presented with many 
classic clinical features of cholera, the diagnosis on admission was 
not immediately obvious. Early differential diagnostic consider-
ations included other infectious agents such as enterotoxigenic E. 
coli, Campylobacter, Salmonella, Shigella and S. aureus. The 
Zollinger-Ellison syndrome was also but less likely a consider-
ation given the patient's previous partial gastrectomy. Other 
noninfectious causes of secretory diarrhea such as the vasoactive 
intestinal polypeptide-secreting tumors and the carcinoid syn-
drome were considered unlikely. 
Vibrio cholera was initially considered to be unlikely. Nei-
ther the patient nor his family, all reliable historians, could reveal 
any history of exposure. Moreover, cholera is known to be 
extremely rare in Hawaii; only 2 previous cases have been 
documented. As a result, the quantity of stool produced was 
initially surprising and underestimated, which made adequate 
fluid resuscitation inadequate in the early hours of hospitalization. 
Regardless of etiology, it is possible that the patient's previ-
ous partial gastrectomy increased his likelihood for contracting 
cholera, as patients with that condition or other causes of 
hypochlorhydria have increased susceptibility to infection1• 
Classification 
There are more than 70 serogroups of Vibrio cholera clas-
sified based on the characteristics of the Somatic 0 antigen. Only 
serogroup 0-l is responsible for epidemic cholera; this is further 
subdivided into 2 biotypes: Classical and El Tor. The El Tor 
biotype differs from the Classical biotype both biochemically 
(hemolysin-producing, polymixin B-resistant) and epidemiologi-
cally (higher infectivity, causing milder infections, hardier in the 
external environment?. Each biotype is further subdivided into 
serotypes based on the presence of additional antigenic determi-
nants. 
Epidemiology 
Vibrio cholera is endemic to the Ganges delta; however, 7 
pandemics have occurred since 18173• The current pandemic of 
the El Tor biotype began in 1961 and encompasses southeast Asia, 
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the Indian subcontinent, the Middle East, Africa and the Gulf 
Coast of North America4• 
Humans are the only host of V. cholera. Transmission occurs 
through human fecal contamination of water and occasionally of 
food (raw vegetables and seafood). However, V. cholera can 
survive in the external environment for limited periods of time. 
Acutely ill patients may excrete up to 60 liters of stool over the 
course of their illness with 107 organisms per milliliter present in 
the stooF. Direct contamination of the environment by improper 
handling of sewage is the major route of epidemic dissemination. 
Additionally, it is speculated that mildly symptomatic and 
asymptomatic patients play an important role in epidemics5. 
In endemic areas, children are affected more frequently than 
are adults; however, it is less common in infants under 2 years of 
age because of passive immunity6• In non-endemic areas, children 
and adults are affected equally. 
Pathogenesis 
Ingestion of approximately 104 organisms is required to 
produce clinical infection7• The ability of V. cholera to colonize 
the lining epithelium of the small intestine is determined by 
adhesion factors, chemotaxis, and motility8• The cholera entero-
toxin, responsible for clinical symptomatology, is composed of 5 
binding subunits and a single activating subunit5• Interaction with 
nicotinamide adenine dinucleotide (NAD) results in increased 
intracellular 3' ,5' adenosine monophosphate (cAMP) and subse-
quent inhibition of the sodium-chloride transport mechanisms. As 
a result, active chloride secretion occurs throughout the intestine. 
The accumulation of isotonic fluid in the small intestine exceeds 
the absorptive capacity of the large intestine, producing the 
characteristic isotonic, bicarbonate-rich stool9• 
Clinical Manifestations 
The incubation period may vary from a few hours to as long 
as 5 days, but is typically 48 to 72 hours2• Most cases are mild and 
clinically indistinguishable from other causes of gastroenteritis4 • 
Severe cases are associated with the production of massive quan-
tities of watery diarrhea often exceeding one liter per hour. 
The degree of dehydration determines the severity of clinical 
symptoms. Severe sequelae include cardiac arrhythmias, acute 
renal failure, and cardiovascular collapse. 
Physical findings reflect loss of intravascular fluid and in-
clude orthostasis, poor skin turgor, hypotension, tachycardia and 
Kussmaul respirations. 
Laboratory abnormalities include hemoconcentration, 
hyponatremia, hypokalemia, metabolic acidosis, elevated blood 
urea nitrogen, creatinine and plasma protein concentration. 
Diagnosis 
The diagnosis of cholera is suspected with the acute onset of 
profuse, watery diarrhea associated with marked dehydration. The 
simplest technique of the direct stool examination with dark-field 
microscopy reveals Vibrios with characteristic helical motility 
patterns. 
Immobilization by adding Group 0-1 antisera is confirmatory, 
if available6• Leukocytes are not seen on methylene blue stain. 
Stool culture is best performed on selective media such as 
MacConkey's, Monsur's, or TCBS (thiosulfate-citrate-bile salt-
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sucrose) agar. Following incubation, suspected Vibrio colonies are 
confirmed by adding Group 0-1 type specific antisera. Differen-
tiation between El Tor and Classical biotypes requires further tests 
forphage-suceptibility, hemolysin-production, and Polymyxin B-
sensitivity. 
Acute infection leads to a rise in vibriocidal and antitoxin 
antibody titers. Titers are elevated by the 5th day of infection, peak 
near the lOth day, and decline over a 6-month period2• A marked 
rise in antibody titer in acute and convalescent serum is highly 
indicative of cholera6• 
In non-epidemic settings, the differential diagnosis of chol-
eraic diarrhea includes other pathogens such as enterotoxigenic E. 
coli, rotavirus and non-01 V. cholera. Rarely, vasoactive, intesti-
nal, polypeptide-secreting tumors (VIPomas) produce choleraic 
diarrhea. 
Treatment and Prognosis 
Prompt replacement of intravascular volume and electrolytes 
is the primary goal of therapy. In severely hypovolemic patients, 
intravenous rehydration is necessary. 
Electrolyte replacement, including potassium and bicarbon-
ate, should parallel stool electrolyte losses. Oral tetracycline 
therapy should be instituted following rehydration to shorten 
disease course. Prophylaxis, however, is not recommended. 
Promptly treated, cholera has a mortality rate ofless than 1 %5• 
Mortality of untreated cases, however, may approach 50% which 
emphasizes the significance of early recognition and treatment. 
Conclusion 
Although rare in Hawaii, cholera should be considered as a 
diagnostic possibility in the setting of acute, profuse secretory 
diarrhea, regardless of risk factors. At the time of this writing, the 
source of this isolated case of cholera remains obscure, and only 
one additional, unrelated case has been reported. 
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